✦ LIBER ✦

Patient reported outcomes of a randomized, placebo-controlled trial of bevacizumab in the front-line treatment of ovarian cancer: A Gynecologic Oncology Group Study

✍ Scribed by Monk, Bradley J.; Huang, Helen Q.; Burger, Robert A.; Mannel, Robert S.; Homesley, Howard D.; Fowler, Jeffrey; Greer, Benjamin E.; Boente, Matthew; Liang, Sharon X.; Wenzel, Lari

Book ID: 123205906
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 389 KB
Volume: 128
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2012.11.038

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Quality of Life Outcomes of a Randomized

Quality of Life Outcomes of a Randomized, Placebo-Controlled Trial of Bevacizumab in the Front-Line Treatment of Ovarian Cancer: a Gynecologic Oncology Group Study

✍ B.J. Monk; H. Huang; R.A. Burger; R.L. Mannel; H.D. Homesley; J. Fowler; B.E. Gr 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 47 KB

A randomized phase III trial of gemcitab

A randomized phase III trial of gemcitabine+docetaxel+bevacizumab or placebo as first-line treatment for metastatic uterine leiomyosarcoma (uLMS): A Gynecologic Oncology Group study

✍ Hensley, M.L.; Miller, A.; O'Malley, D.M.; Mannel, R.S.; Behbakht, K.; Bakkum-Ga 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 110 KB

Cytokine use and survival in the first-l

Cytokine use and survival in the first-line treatment of ovarian cancer: A Gynecologic Oncology Group Study

✍ Frederick B. Stehman; Mark F. Brady; J. Tate Thigpen; Emma C. Rossi; Robert A. B 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 523 KB

Phase II Trial of Bevacizumab in Persist

Phase II Trial of Bevacizumab in Persistent or Recurrent Epithelial Ovarian Cancer or Primary Peritoneal Cancer: A Gynecologic Oncology Group Study

✍ Burger, R. A.; Sill, M. W.; Monk, B. J.; Greer, B. E.; Sorosky, J. I. 📂 Article 📅 2007 🏛 American Society of Clinical Oncology 🌐 English ⚖ 112 KB

Impact of cytokine use on survival in th

Impact of cytokine use on survival in the first-line treatment of ovarian cancer: A Gynecologic Oncology Group study

✍ E. Rossi; M. Brady; J. Thigpen; F. Stehman; R. Burger 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 109 KB

Cognitive function during chemotherapy f

Cognitive function during chemotherapy for front-line treatment of ovarian, primary peritoneal or fallopian tube cancer: A Gynecologic Oncology Group study

✍ Hess, L.; Huang, H.; Robinson, W.; Johnson, R.; Alberts, D. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 193 KB